KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $7,550,000 | +4.0% | 731,558 | +6.0% | 0.14% | -8.4% |
Q1 2021 | $7,263,000 | -6.6% | 690,410 | +37.4% | 0.15% | -12.0% |
Q4 2020 | $7,779,000 | +99.1% | 502,542 | +87.7% | 0.18% | +31.6% |
Q3 2020 | $3,908,000 | -52.9% | 267,697 | -38.9% | 0.13% | -55.7% |
Q2 2020 | $8,297,000 | – | 438,081 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |